WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
OAKLAND, Calif., Jan. 8 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT ) World Heart Corporation ("WorldHeart") announced today that it has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration ("FDA" or the "Agency") for a pivotal Bridge-to-Transpla...Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...Thoratec Schedules Second Quarter Conference Call, Webcast
... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...Thoratec Announces Appointment of Paul LaViolette to Board of Directors
... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...Thoratec Presentation at JMP Securities Conference to be Webcast
...oratec.com . Thoratec is world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from ...Thoratec Schedules First Quarter Conference Call, Webcast
... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...Artificial pump effectively backs up failing hearts
... the trial included stroke and bleeding, and the number and type of adverse events was similar to other LVADs but better than that of first-generation vad devices. Answering standardized questionnaires for patients with heart failure, they reported a significantly improved quality of life after receiv...Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
...atec Corporation Thoratec is a leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...Thoratec Presentation at Raymond James Conference to Be Webcast
...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
... 4706062. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its Int...Thoratec Reports 34 Percent Increase in 2008 Revenues
...ing growing penetration with the HeartMate II and the continued addition of vad therapy at a number of open-heart centers. Most importantly, we will be dri...ed-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS (Left Ventricular Assist Sys...Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...Thoratec Presentation at Piper Jaffary Conference to be Webcast
...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
...cial measures. Thoratec is a world leader in therapies to address advanced stage heart failure. The company's product lines include the Thoratec(R) vad and HeartMate LVAS with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporati...Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
...78. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate (R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from he...Thoratec Schedules First Quarter 2008 Conference Call, Webcast
...00. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from ...National study will look at German-made heart pump for children needing heart transplants
...atric heart pump. At the studys conclusion, Berlin Heart, Inc. will present those data to the FDA for consideration of approval of the EXCOR Pediatric vad for use in the U.S. The Berlin Heart holds a lot of promise for infants and children whose hearts are failing, said Fraser. Its extremely gratifying ...Pumps Someday May Allow Patients to Recover Their Own Hearts
...of cardiac transplantation and mechanical support. Why is he so confident? Because he and other physicians have seen the kind of heart healing a vad can provide. Functioning essentially as surrogate pumps for the heart, the devices have been used for years to help patients who are poor candidates f...Review Urges Restricted Use Of Devices To Keep Heart Patients Alive
...erse events, but it's certainly better than before vad implantation." The small number of heart-pump...viewers compared health outcomes and costs for the vad patients with patients on the UK's heart transplan...st. The review estimates the average cost of a vad implant operation is 63,830 British pounds (roughl...Drug Effective for Vascular Dementia
...l of the condition.// Vascular dementia -- or vad -- is usually associated with cardiovascular disea...ple of their cognitive abilities slowly over time, vad often strikes quickly, such as after a stroke. How...rve fiber) deficit, leading researchers to believe vad patients may also benefit from treatment with chol...